Stockreport

Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 29.4% Operating Margin

ABIOMED, Inc.  (ABMD) 
Last abiomed, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.abiomed.com/investor-relations
PDF DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quar [Read more]